Dexamethasone Modifies Cystatin C-Based Diagnosis of Acute Kidney Injury During Cisplatin-Based Chemotherapy

Dexamethasone Modifies Cystatin C-Based Diagnosis of Acute Kidney Injury During Cisplatin-Based Chemotherapy

Background/Aims: Plasma cystatin C (pCysC) may be superior to serum creatinine (sCr) as a surrogate of GFR. However, the performance of pCysC for diagnosing acute kidney injury (AKI) after cisplatin-based chemotherapy is potentially affected by accompanying corticosteroid anti-emetic therapy and hyd...

Full description

Bibliographic Details
Main Authors: Timothy J. Pianta, John W. Pickering, Lena Succar, Melvin Chin, Trent Davidson, Nicholas A. Buckley, Fahim Mohamed, Zoltan H. Endre
Format: Article
Language:English
Published: Karger Publishers 2017-03-01
Series:Kidney & Blood Pressure Research
Subjects:
Cystatin C
Creatinine
Acute kidney injury
Biomarkers
Dexamethasone
Online Access:http://www.karger.com/Article/FullText/469715

Similar Items

Similar Items